{"url":"https://lda.senate.gov/api/v1/filings/d17dc243-03ad-4e8a-b0b9-0052214c8a87/","filing_uuid":"d17dc243-03ad-4e8a-b0b9-0052214c8a87","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d17dc243-03ad-4e8a-b0b9-0052214c8a87/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Frank J Howard Jr","dt_posted":"2023-04-17T17:40:54-04:00","termination_date":"2022-12-30","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"13007 Woodbridge Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Studio City","registrant_state":"CA","registrant_zip":"96104","registrant":{"id":401105612,"url":"https://lda.senate.gov/api/v1/registrants/401105612/","house_registrant_id":null,"name":"KLINK CAMPAIGNS, INC","description":"Contracting lobbying and public affairs firm","address_1":"13007 Woodbridge Street","address_2":null,"address_3":null,"address_4":null,"city":"Studio City","state":"CA","state_display":"California","zip":"96104","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"FRANK HOWARD JR","contact_telephone":"+1 202-505-0506","dt_updated":"2023-10-14T18:25:21.685483-04:00"},"client":{"id":205771,"url":"https://lda.senate.gov/api/v1/clients/205771/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)","general_description":"PhRMA represents the countrys leading innovative biopharmaceutical research companies.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-01-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medicaid & Medicare COVID-19 Research and development of biopharmaceuticals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":92673,"prefix":null,"prefix_display":null,"first_name":"FRANK","nickname":null,"middle_name":"J","last_name":"HOWARD","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ECN","general_issue_code_display":"Economics/Economic Development","description":"Economic impact of the biopharmaceutical industry Research and development of biopharmaceuticals Inflation Reduction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":92673,"prefix":null,"prefix_display":null,"first_name":"FRANK","nickname":null,"middle_name":"J","last_name":"HOWARD","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}